Trademark: 77000989
Status Date
Monday, February 14, 2011
Filing Date
Friday, September 15, 2006
Published for Opposition
Tuesday, October 23, 2007
Abandoned Date
Monday, February 14, 2011
5 Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Feb 14, 2011
Abandonment Notice Mailed - No Use Statement Filed
Feb 14, 2011
Abandonment - No Use Statement Filed
Jun 18, 2010
Notice Of Approval Of Extension Request E-Mailed
Jun 17, 2010
Extension 5 Granted
Jun 7, 2010
Extension 5 Filed
Jun 7, 2010
Teas Extension Received
Dec 17, 2009
Extension 4 Granted
Dec 5, 2009
Extension 4 Filed
Dec 5, 2009
Teas Extension Received
Jul 29, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 21, 2009
Paper Received
May 29, 2009
Extension 3 Granted
May 28, 2009
Extension 3 Filed
May 28, 2009
Teas Extension Received
Jan 7, 2009
Extension 2 Granted
Dec 17, 2008
Extension 2 Filed
Jan 7, 2009
Case Assigned To Intent To Use Paralegal
Dec 17, 2008
Teas Extension Received
Jul 11, 2008
Extension 1 Granted
Jul 2, 2008
Extension 1 Filed
Jul 2, 2008
Teas Extension Received
Jan 15, 2008
Noa Mailed - Sou Required From Applicant
Oct 23, 2007
Published For Opposition
Oct 3, 2007
Notice Of Publication
Sep 18, 2007
Law Office Publication Review Completed
Sep 18, 2007
Assigned To Lie
Aug 10, 2007
Approved For Pub - Principal Register
Aug 8, 2007
Teas/Email Correspondence Entered
Aug 7, 2007
Correspondence Received In Law Office
Aug 7, 2007
Teas Response To Office Action Received
Feb 8, 2007
Non-Final Action E-Mailed
Feb 8, 2007
Non-Final Action Written
Feb 6, 2007
Assigned To Examiner
Sep 20, 2006
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
